ReviewBlood and lymphatic cancer : targets and therapy2017

Impact of obinutuzumab alone and in combination for follicular lymphoma.

Maryam Sarraf Yazdy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.